Dr. Gibson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3433 Nw 56th St
Ste 400
Oklahoma City, OK 73112Phone+1 405-947-3341
Education & Training
- Louisiana State UniversityFellowship, Cardiovascular Disease, 1999 - 2002
- Louisiana State University School of MedicineResidency, Internal Medicine/Pediatrics, 1995 - 1999
- LSU School of Medicine in ShreveportClass of 1995
Certifications & Licensure
- OK State Medical License 2003 - 2025
- LA State Medical License 1996 - 2005
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Publications & Presentations
PubMed
- 111 citationsDirect vascular and cardioprotective effects of rosuvastatin, a new HMG-CoA reductase inhibitor.Steven P. Jones, Michael F. Gibson, David M. Rimmer, Terrie M Gibson, Brent R. Sharp
Journal of the American College of Cardiology. 2002-09-18
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: